Strattera (Atomoxetine) and Heart Health: Cardiovascular Risks and Monitoring
Strattera, a non-stimulant ADHD medication, is generally well-tolerated but carries potential cardiovascular effects:
- Increased heart rate: Usually mild and transient; monitor if history of heart conditions.
- Blood pressure changes: May increase or decrease; regular monitoring advised, especially with hypertension history.
- Rare cardiovascular events: Heart attack, stroke, arrhythmia—risk higher with pre-existing conditions or high doses.
- QTc prolongation: Can lengthen the QT interval; rarely leads to torsades de pointes.
Overall cardiovascular risk is low, and benefits often outweigh risks. Discuss any heart concerns with your doctor before starting and during treatment.
Cardiovascular Disease - Related Articles
- Nebulizer Therapy for Cardiac Patients: Benefits & Medications
- Venous Insufficiency vs. Peripheral Artery Disease: Key Differences
- Becoming a Cardiovascular Perfusionist: Education & Requirements
- Smoking and Cardiovascular Disease: Understanding the Risks
- How Diet Drives Coronary Heart Disease: 6 Mechanistic Pathways
- Optimizing Cardiovascular Health: A Comprehensive Guide
- Caffeine-Induced Vasoconstriction: Adenosine Receptor Antagonism Mechanism
